Metraipolis › archive › dc_5fcf8f5631df

Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in… — Europe PMC PMID:41299232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41299232
DOI
10.1186/s10194-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-08T06:25:13.529Z
SHA-256 of the archived text
f54014904f68516e587389969cd01cd26b3556d13465b959f9c09fba6b31fd3b
Stable URL of this page
https://metraipolis.com/documento/dc_5fcf8f5631df

How to cite

Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in… — Europe PMC PMID:41299232 — Europe PMC (en), https://europepmc.org/article/MED/41299232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5fcf8f5631df (Metraipolis archive dc_5fcf8f5631df, sha256 f54014904f68516e587389969cd01cd26b3556d13465b959f9c09fba6b31fd3b)
BibTeX
@misc{dc5fcf8f5631df,
  title = {Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in… — Europe PMC PMID:41299232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41299232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5fcf8f5631df; sha256 f54014904f68516e587389969cd01cd26b3556d13465b959f9c09fba6b31fd3b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41299232. Agents can read the archived copy with the MCP tool read_document.